Global Burden of 5 Major Types of Gastrointestinal Cancer

Gastroenterology - Tập 159 - Trang 335-349.e15 - 2020
Melina Arnold1, Christian C. Abnet2, Rachel E. Neale3, Jerome Vignat1, Edward L. Giovannucci4, Katherine A. McGlynn2, Freddie Bray1
1Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France
2Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
3Population Health Division, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia
4Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

Tài liệu tham khảo

Ferlay Islami, 2018, Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, CA Cancer J Clin, 68, 31, 10.3322/caac.21440 2015 2018 2012 2016 2016 Song, 2016, Preventable incidence and mortality of carcinoma associated with lifestyle factors among white adults in the United States, JAMA Oncol, 2, 1154, 10.1001/jamaoncol.2016.0843 Arnold, 2015, Global burden of cancer attributable to high body-mass index in 2012: a population-based study, Lancet Oncol, 16, 36, 10.1016/S1470-2045(14)71123-4 Allemani, 2018, Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries, Lancet, 391, 1023, 10.1016/S0140-6736(17)33326-3 Arnold, 2019, Progress in cancer survival, mortality, and incidence in seven high- income countries 1995-2014 (ICBP SURVMARK-2): a population-based study, Lancet Oncol, 20, 1493, 10.1016/S1470-2045(19)30456-5 Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Tomorrow. Lyon, France: International Agency for Research on Cancer. Available at: https://gco.iarc.fr/tomorrow; 2018. Accessed January 15, 2020. 2019 Ferlay, 2018 Bray F, Colombet M, Mery L, et al, eds. Cancer Incidence in Five Continents, Vol. XI (electronic version). Lyon: International Agency for Research on Cancer, 2017. Available at: https://ci5.iarc.fr. Accessed January 15, 2020. Segi, 1960 Day, 1976, A new measure of age standardized incidence, the cumulative rate, 443 Arnold, 2015, Global incidence of oesophageal cancer by histological subtype in 2012, Gut, 64, 381, 10.1136/gutjnl-2014-308124 Abnet, 2018, Epidemiology of esophageal squamous cell carcinoma, Gastroenterology, 154, 360, 10.1053/j.gastro.2017.08.023 Sheikh, 2019, Individual and combined effects of environmental risk factors for esophageal cancer based on results from the Golestan cohort study, Gastroenterology, 156, 1416, 10.1053/j.gastro.2018.12.024 Semnani, 2005, Esophageal cancer in northeastern Iran, Indian J Gastroenterol, 24, 224 Loon, 2018, The African Esophageal Cancer Consortium: a call to action, J Glob Oncol, 4, 1 McColl, 2019, What is causing the rising incidence of esophageal adenocarcinoma in the West and will it also happen in the East?, J Gastroenterol, 54, 669, 10.1007/s00535-019-01593-7 Thrift, 2016, The epidemic of oesophageal carcinoma: where are we now?, Cancer Epidemiol, 41, 88, 10.1016/j.canep.2016.01.013 Arnold, 2017, Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030, Am J Gastroenterol, 112, 1247, 10.1038/ajg.2017.155 Wei, 2015, Long-term follow-up of a community assignment, one-time endoscopic screening study of esophageal cancer in China, J Clin Oncol, 33, 1951, 10.1200/JCO.2014.58.0423 Zeng, 2018, Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries, Lancet Glob Health, 6, e555, 10.1016/S2214-109X(18)30127-X Lao-Sirieix, 2012, Screening for oesophageal cancer, Nat Rev Clin Oncol, 9, 278, 10.1038/nrclinonc.2012.35 Offman, 2018, Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux, BMC Cancer, 18, 784, 10.1186/s12885-018-4664-3 Howson, 1986, The decline in gastric cancer: epidemiology of an unplanned triumph, Epidemiol Rev, 8, 1, 10.1093/oxfordjournals.epirev.a036288 Hooi, 2017, Global Prevalence of Helicobacter pylori infection: systematic review and meta-analysis, Gastroenterology, 153, 420, 10.1053/j.gastro.2017.04.022 Praud, 2018, Cigarette smoking and gastric cancer in the Stomach Cancer Pooling (StoP) Project, Eur J Cancer Prev, 27, 124, 10.1097/CEJ.0000000000000290 Rota, 2017, Alcohol consumption and gastric cancer risk—a pooled analysis within the StoP project consortium, Int J Cancer, 141, 1950, 10.1002/ijc.30891 de Martel, 2020, Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis, Lancet Global Health, 8, e180, 10.1016/S2214-109X(19)30488-7 Hoyo, 2012, Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium, Int J Epidemiol, 41, 1706, 10.1093/ije/dys176 Kamangar, 2006, Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity, J Natl Cancer Inst, 98, 1445, 10.1093/jnci/djj393 Colquhoun, 2015, Global patterns of cardia and non-cardia gastric cancer incidence in 2012, Gut, 64, 1881, 10.1136/gutjnl-2014-308915 Taghavi, 2007, Epidemiology of upper gastrointestinal cancers in Iran: a sub site analysis of 761 cases, World J Gastroenterol, 13, 5367, 10.3748/wjg.v13.i40.5367 Babaei, 2010, Gastric cancer in Ardabil, Iran—a review and update on cancer registry data, Asian Pac J Cancer Prev, 11, 595 Gupta, 2019, Race/ethnicity-, socioeconomic status-, and anatomic subsite-specific risks for gastric cancer, Gastroenterology, 156, 59, 10.1053/j.gastro.2018.09.045 Anderson, 2018, The changing face of noncardia gastric cancer incidence among US non-Hispanic whites, J Natl Cancer Inst, 110, 608, 10.1093/jnci/djx262 Camargo, 2011, Divergent trends for gastric cancer incidence by anatomical subsite in US adults, Gut, 60, 1644, 10.1136/gut.2010.236737 2020, The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017, Lancet Gastroenterol Hepatol, 5, 42, 10.1016/S2468-1253(19)30328-0 Jung, 2019, Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2016, Cancer Res Treat, 51, 417, 10.4143/crt.2019.138 Matsuda, 2018, Cancer burden in Japan based on the latest cancer statistics: need for evidence-based cancer control programs, Ann Cancer Epidemiol, 2, 10.21037/ace.2018.08.01 Hamashima, 2018, Systematic Review Group and Guideline Development Group for Gastric Cancer Screening Guidelines. Update version of the Japanese Guidelines for Gastric Cancer Screening, Jpn J Clin Oncol, 48, 673, 10.1093/jjco/hyy077 Jun, 2017, Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality, Gastroenterology, 152, 1319, 10.1053/j.gastro.2017.01.029 Ford, 2014, Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials, BMJ, 348, g3174, 10.1136/bmj.g3174 Areia, 2013, Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies, Helicobacter, 18, 325, 10.1111/hel.12050 Fidler, 2017, Assessing global transitions in human development and colorectal cancer incidence, Int J Cancer, 140, 2709, 10.1002/ijc.30686 Fedirko, 2011, Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies, Ann Oncol, 22, 10.1093/annonc/mdq653 Bouvard, 2015, Carcinogenicity of consumption of red and processed meat, Lancet Oncol, 16, 1599, 10.1016/S1470-2045(15)00444-1 Norat, 2002, Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies, Int J Cancer, 98, 241, 10.1002/ijc.10126 Renehan, 2008, Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies, Lancet, 371, 569, 10.1016/S0140-6736(08)60269-X Botteri, 2008, Smoking and colorectal cancer: a meta-analysis, JAMA, 300, 2765, 10.1001/jama.2008.839 2019, The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet Gastroenterol Hepatol, 4, 913, 10.1016/S2468-1253(19)30345-0 Lauby-Secretan, 2018, The IARC perspective on colorectal cancer screening, N Engl J Med, 378, 1734, 10.1056/NEJMsr1714643 Schreuders, 2015, Colorectal cancer screening: a global overview of existing programmes, Gut, 64, 1637, 10.1136/gutjnl-2014-309086 Araghi, 2019, Changes in colorectal cancer incidence in seven high-income countries: a population-based study, Lancet Gastroenterol Hepatol, 4, 511, 10.1016/S2468-1253(19)30147-5 Siegel, 2017, Colorectal cancer incidence patterns in the United States, 1974–2013, J Natl Cancer Inst, 109, 10.1093/jnci/djw322 Vuik, 2019, Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years, Gut, 68, 1820, 10.1136/gutjnl-2018-317592 Pilleron, 2019, Global cancer incidence in older adults, 2012 and 2035: a population-based study, Int J Cancer, 144, 49, 10.1002/ijc.31664 Khan, 2005, Cholangiocarcinoma. Lancet, 366, 1303, 10.1016/S0140-6736(05)67530-7 Petrick, 2019, The changing epidemiology of primary liver cancer, Curr Epidemiol Rep, 6, 104, 10.1007/s40471-019-00188-3 Di Cesare, 2016, Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants, Lancet, 387, 1377, 10.1016/S0140-6736(16)30054-X 2016, Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants, Lancet, 387, 1513, 10.1016/S0140-6736(16)00618-8 Chang, 1997, Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group, N Engl J Med, 336, 1855, 10.1056/NEJM199706263362602 Chang, 2009, Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study, J Natl Cancer Inst, 101, 1348, 10.1093/jnci/djp288 Prueksapanich, 2018, Liver fluke-associated biliary tract cancer, Gut Liver, 12, 236, 10.5009/gnl17102 Petrick, 2019, International trends in hepatocellular carcinoma incidence, 1978–2012, Int J Cancer Songserm, 2012, Risk factors for cholangiocarcinoma in high-risk area of Thailand: role of lifestyle, diet and methylenetetrahydrofolate reductase polymorphisms, Cancer Epidemiol, 36, e89, 10.1016/j.canep.2011.11.007 2019, The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet Gastroenterol Hepatol, 4, 934, 10.1016/S2468-1253(19)30347-4 Kleeff, 2016, Pancreatic cancer, Nat Rev Dis Primers, 2, 16022, 10.1038/nrdp.2016.22 Huang, 2018, Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study, BMC Med, 16, 125, 10.1186/s12916-018-1120-9 Ferlay, 2016, More deaths from pancreatic cancer than breast cancer in the EU by 2017, Acta Oncol, 55, 1158, 10.1080/0284186X.2016.1197419 Sung, 2019, Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry, Lancet Public Health, 4, e137, 10.1016/S2468-2667(18)30267-6 Keum, 2016, Association of physical activity by type and intensity with digestive system cancer risk, JAMA Oncol, 2, 1146, 10.1001/jamaoncol.2016.0740 Moore, 2016, Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults, JAMA Intern Med, 176, 816, 10.1001/jamainternmed.2016.1548 Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 68, 394, 10.3322/caac.21492 2013